Product logo
  • Home
  • Sign Up
Product logo

Torrent Pharmaceuticals Ltd

News

Switch to
More ontickertape logoapp
    Home
    Sign Up

    Torrent Pharmaceuticals Ltd

    TORNTPHARM
    1,556.6520.55 (+1.34%)
    Scorecard

    Performance

    Avg

    Price return has been average, nothing exciting

    Valuation

    High

    Seems to be overvalued vs the market average

    Growth

    Avg

    Financials growth has been moderate for a few years

    Profitability

    High

    Showing good signs of profitability & efficiency

    Entry point

    Avg

    The stock is overpriced but is not in the overbought zone

    Red flags

    Low

    No red flag found

    Get your Zerodha accountOpen Now

    Go Pro! to unlock score, rank

    and other metrics

    How to use scorecard? Learn more

    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    1.0 k

    News & Opinions

    1.0 k
    Articles & Videos
    News Thumbnail

    Buy Torrent Pharmaceuticals; target of Rs 1915: Anand Rathi

    1 week ago•Moneycontrol

    News Thumbnail

    Buy Torrent Pharmaceuticals, target of Rs 1788: Sharekhan

    1 week ago•Moneycontrol

    News Thumbnail

    Buy Torrent Pharmaceuticals; target of Rs 1820: Prabhudas Lilladher

    1 week ago•Moneycontrol

    News Thumbnail

    Torrent Pharma Q3 PAT rises 14% YoY to Rs 283 cr

    1 week ago•Business Standard

    News Thumbnail

    Torrent Pharma Q3 Results Review - Branded Generics, The U.S. Led Earnings Growth Revival: Motilal Oswal

    1 week ago•Bloomberg Quint

    News Thumbnail

    Pharma stock declares 280% dividend. Check payment date, other details

    1 week ago•Livemint

    News Thumbnail

    Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil

    2 weeks ago•Business Standard

    © Powered byTickertape.ViewTORNTPHARMon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019